Diabetic nephropathy (DN) accounts for 50% of end stage renal diseases (ESRD). It is mandatory to search for new prognostic markers like plasma copeptin that could facilitate early diagnosis, treatment and wise planning of treatment strategy. Little studies were performed on the relation between Plasma copeptin and diabetic nephropathy, yet this relationship is unclear and needs further investigations.